📉 Dividendhike.com Portfolio Update: Red Numbers, But Far from Red Flags
Market Setback Creates Opportunities: Navigating the Decline with a Focus on Long-Term Dividend Growth
As of April 4, 2025, our Dividendhike Portfolio is showing a -7.4% total return. Not a great feeling, we know. Losses hurt—no way around it. But context matters: the Dividendhike Portfolio is actually holding up better than the broader market.
Take the S&P 500, which is down nearly 14% year-to-date. The Nasdaq and Russell 2000 are performing even worse. So yes, we’re down—but in relative terms, it’s a shallower dip than most.
Long term Focus
Despite the red numbers, the core philosophy behind this portfolio hasn’t changed. Every stock we hold shares a defining trait: they raise their dividend every year—consistently and at an above-average rate.
That commitment to returning capital to shareholders makes these businesses resilient and shareholder-friendly. Even with economic headwinds, we still believe these companies will continue growing their dividends in 2025, tariffs or not.
Historically, periods of widespread market decline have proven to be great long-term buying opportunities, particularly for income investors. That’s not advice—just perspective.
When reviewing the portfolio as of April 4, 2025, there are a few notable outliers that have had a significant impact—both positive and negative—on the overall performance.
For instance, Abbott Laboratories ABT 0.00%↑ stands out as one of the positive performers. The stock has appreciated by 10% since the initial purchase, despite a recent drop of 4.9% over the past week. The dividend yield remains stable at 1.9%, adding to the overall return and reinforcing its long-term growth potential.
On the negative side, Williams-Sonoma WSM 0.00%↑ has seen a significant decline, down 23.5% since the purchase. The stock has been heavily impacted by the recent market downturn, and it dropped another 10.9% in the past week.
Semiconductors and cyclicals were hit especially hard, as trade-related uncertainty and macro headwinds weighed heavily: 4 stocks lost more than 20% last week. Let’s dive into the portfolio with all updated stats en yields.